After pricing controversy, EpiPen maker offers cheaper, generic version
Monday, August 29, 2016 - 09:31
in Mathematics & Economics
Ed AdamczykPITTSBURGH, Aug. 29 (UPI) -- Mylan N.V. announced a lower-cost generic version of the EpiPen after U.S. senators railed against the steep price increase to $500 last week.